Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1119 issues

How to Get Oxervate (Cenegermin) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Get Oxervate Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Oxervate (cenegermin) with specific criteria: confirmed Stage 2 or 3 neurotrophic keratitis diagnosis and documented failure of at least one OTC artificial tear product. Submit PA through the OptumRx portal or fax to 1-844-403-1027. If

If Tremfya (Guselkumab) Isn't Approved by UnitedHealthcare in Georgia: Formulary Alternatives & Exception Paths

Answer Box: Tremfya Alternatives & Exception Strategy If UnitedHealthcare denies Tremfya (guselkumab) in Georgia, you have three main paths: try a formulary-preferred biologic first (often adalimumab or secukinumab), request a step therapy exception with clinical documentation, or appeal through Georgia's external review process within 60 days. Start by

Work With Your Doctor to Get Zanzalintinib (XL092) Approved by UnitedHealthcare in Virginia: Clinical Evidence, Appeals, and Expanded Access

Answer Box: Getting Started Zanzalintinib (XL092) is investigational and typically requires expanded access through Exelixis rather than insurance coverage. However, if your oncologist believes insurance coverage for routine care costs is appropriate, here's your fastest path: 1. Visit prep: Gather your complete treatment history, molecular testing results, and

Get Haegarda (C1-esterase inhibitor, SC) Covered by UnitedHealthcare in Virginia: Appeals, Step Therapy Overrides, and State External Review

Answer Box: UnitedHealthcare requires prior authorization for Haegarda (C1-esterase inhibitor, SC) in Virginia. You need confirmed HAE diagnosis, attack history documentation, and specialist support. If denied, Virginia law provides step therapy exceptions and external review through the State Corporation Commission Bureau of Insurance within 120 days. Start by gathering HAE

How to Get Fintepla (fenfluramine) Approved by UnitedHealthcare in California: Complete Timeline & Appeals Guide

Answer Box: Getting Fintepla Approved by UnitedHealthcare in California Timeline: UnitedHealthcare typically decides Fintepla prior authorization requests within 24-72 hours for complete submissions, with urgent cases processed in ≤24 hours. Fastest path: Submit electronic PA with complete REMS enrollment documentation, baseline echocardiogram, and detailed seizure history. First step today: Call

How to Get Sumatriptan Injection Covered by UnitedHealthcare in New York: Prior Authorization Guide & Appeal Templates

Quick Answer: Getting Sumatriptan Injection Covered by UnitedHealthcare in New York Note: Sumavel DosePro was discontinued in the U.S. UnitedHealthcare now covers generic sumatriptan injection auto-injectors with prior authorization. You'll need to document failed oral triptan trials and medical necessity for injectable route. If denied, you have

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in New Jersey: Complete Coding, Appeals, and External Review Guide

Answer Box: Getting Oxlumo (lumasiran) Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1), with coverage based on genetic confirmation, specialist prescribing, and documented oxalate elevation. If denied, you have internal appeals followed by New Jersey's IHCAP external

Getting Skyrizi (Risankizumab) Covered by UnitedHealthcare in Washington: A Complete Approval Guide

Answer Box: Your Fastest Path to Skyrizi Coverage Getting Skyrizi (risankizumab) covered by UnitedHealthcare in Washington requires prior authorization. Most approvals succeed when you document moderate-to-severe disease and show failure of at least one conventional therapy or targeted biologic. Start today by: (1) calling UnitedHealthcare member services to confirm your

Renewing Your Vitrakvi (Larotrectinib) Approval with UnitedHealthcare in Michigan: 2025 Documentation Requirements and Timeline Guide

Answer Box: Quick Start Guide UnitedHealthcare requires annual reauthorization for Vitrakvi (larotrectinib) in Michigan, typically processed through OptumRx. Start the renewal process 3-4 weeks before your current authorization expires. You'll need recent oncology notes showing "no evidence of progressive disease" and updated imaging results. Submit via

Renewing Xospata (Gilteritinib) Approval with UnitedHealthcare in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Renewing Xospata Coverage with UnitedHealthcare in Pennsylvania To renew Xospata (gilteritinib) approval with UnitedHealthcare in Pennsylvania, start the process 30 days before your current authorization expires. You'll need recent oncology notes showing disease response or stability, updated FLT3 mutation documentation, and evidence of tolerability. Submit through